P537: SAFETY AND TOLERABILITY OF AZD0466 AS MONOTHERAPY FOR PATIENTS WITH ADVANCED HEMATOLOGICAL MALIGNANCIES - PRELIMINARY RESULTS FROM AN ONGOING PHASE I/II TRIAL

• Giovanni Marconi,
• Shukaib Arslan,
• Shaun Fleming,
• Antonio Curti,
• James S Blachly,
• Giovanni Martinelli,
• Matteo Giovanni Della Porta,
• Ashish Bajel,
• Tim Sauer,
• Martina Crysandt,
• Arnaud Pigneux,
• Marina Konopleva,
• Yotvat Marmor,
• Shringi Sharma,
• Nairouz Elgeioushi,
• Emily Rowe,
• Patricia Cheung,
• Ekaterina Jahn,
• Jamal Saeh,
• Raoul Tibes,
• Fathima Zumla Cader,
• Nitin Jain

Affiliations

Giovanni Marconi

1 IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori”, Meldola, Italy

Shukaib Arslan

2 City of Hope National Medical Center, Duarte, United States

Shaun Fleming

3 Alfred Hospital, Department of Clinical Haematology, Melbourne, Australia

Antonio Curti

4 IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy

James S Blachly

5 The Ohio State University James Comprehensive Cancer Center, Columbus, United States

Giovanni Martinelli

1 IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori”, Meldola, Italy

Matteo Giovanni Della Porta

6 Humanitas Clinical and Research Center – IRCCS, Milan, Italy

Ashish Bajel

7 Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Australia

Tim Sauer

8 Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany

Martina Crysandt

9 Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany

Arnaud Pigneux

10 Hématologie Clinique et Thérapie cellulaire, CHU Bordeaux, Bordeaux, France

Marina Konopleva

11 Albert Einstein College of Medicine, Jack and Pearl Resnick Campus, Bronx, New York, United States

Yotvat Marmor

12 Hematology Oncology R&D, AstraZeneca, Cambridge, United Kingdom

Shringi Sharma

12 Hematology Oncology R&D, AstraZeneca, Cambridge, United Kingdom

Nairouz Elgeioushi

12 Hematology Oncology R&D, AstraZeneca, Cambridge, United Kingdom

Emily Rowe

12 Hematology Oncology R&D, AstraZeneca, Cambridge, United Kingdom

Patricia Cheung

12 Hematology Oncology R&D, AstraZeneca, Cambridge, United Kingdom

Ekaterina Jahn

12 Hematology Oncology R&D, AstraZeneca, Cambridge, United Kingdom

Jamal Saeh

12 Hematology Oncology R&D, AstraZeneca, Cambridge, United Kingdom

Raoul Tibes

12 Hematology Oncology R&D, AstraZeneca, Cambridge, United Kingdom

Fathima Zumla Cader

12 Hematology Oncology R&D, AstraZeneca, Cambridge, United Kingdom

Nitin Jain

13 MD Anderson Cancer Center, Houston, United States